These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 8028659)

  • 1. Tumor-suppressor genes. Open questions on p16.
    Bonetta L
    Nature; 1994 Jul; 370(6486):180. PubMed ID: 8028659
    [No Abstract]   [Full Text] [Related]  

  • 2. p16 gene in uncultured tumours.
    Spruck CH; Gonzalez-Zulueta M; Shibata A; Simoneau AR; Lin MF; Gonzales F; Tsai YC; Jones PA
    Nature; 1994 Jul; 370(6486):183-4. PubMed ID: 8028660
    [No Abstract]   [Full Text] [Related]  

  • 3. Deletion and mutation analyses of the P16/MTS-1 tumor suppressor gene in human ductal pancreatic cancer reveals a higher frequency of abnormalities in tumor-derived cell lines than in primary ductal adenocarcinomas.
    Huang L; Goodrow TL; Zhang SY; Klein-Szanto AJ; Chang H; Ruggeri BA
    Cancer Res; 1996 Mar; 56(5):1137-41. PubMed ID: 8640773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of the cyclin-dependent kinase inhibitors p16 and p21 in the human melanocytic system.
    Wang Y; Becker D
    Oncogene; 1996 Mar; 12(5):1069-75. PubMed ID: 8649798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
    Elisei R; Shiohara M; Koeffler HP; Fagin JA
    Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of p16INK4A/CDKN2 and p15INK4B in human somatic cell hybrids and hybrid-derived tumors.
    Kuerbitz SJ; Malandro J; Compitello N; Baylin SB; Graff JR
    Cell Growth Differ; 1999 Jan; 10(1):27-33. PubMed ID: 9950215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of mutation in the cyclin-dependent kinase inhibitor, p19INK4d, in tumor-derived cell lines and primary tumors.
    Zariwala M; Xiong Y
    Oncogene; 1996 Nov; 13(9):2033-8. PubMed ID: 8934552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
    Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
    J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p16 (CDKN2/cyclin-dependent kinase-4 inhibitor/multiple tumor suppressor-1) gene is not altered in uterine cervical carcinomas or cell lines.
    Hirama T; Miller CW; Wilczynski SP; Koeffler HP
    Mod Pathol; 1996 Jan; 9(1):26-31. PubMed ID: 8821952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDKN2 (MTS1) tumor suppressor gene mutations in human tumor cell lines.
    Liu Q; Neuhausen S; McClure M; Frye C; Weaver-Feldhaus J; Gruis NA; Eddington K; Allalunis-Turner MJ; Skolnick MH; Fujimura FK
    Oncogene; 1995 Dec; 11(11):2455. PubMed ID: 8570198
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression.
    Geradts J; Kratzke RA; Niehans GA; Lincoln CE
    Cancer Res; 1995 Dec; 55(24):6006-11. PubMed ID: 8521382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of p16(INK4A) induces dominant suppression of glioblastoma growth in situ through necrosis and cell cycle arrest.
    Hung KS; Hong CY; Lee J; Lin SK; Huang SC; Wang TM; Tse V; Sliverberg GD; Weng SC; Hsiao M
    Biochem Biophys Res Commun; 2000 Mar; 269(3):718-25. PubMed ID: 10720483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly frequent homozygous deletion of the p16 gene in esophageal cancer cell lines.
    Igaki H; Sasaki H; Kishi T; Sakamoto H; Tachimori Y; Kato H; Watanabe H; Sugimura T; Terada M
    Biochem Biophys Res Commun; 1994 Sep; 203(2):1090-5. PubMed ID: 8093026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational analysis of the p16 family cyclin-dependent kinase inhibitors p15INK4b and p18INK4c in tumor-derived cell lines and primary tumors.
    Zariwala M; Liu E; Xiong Y
    Oncogene; 1996 Jan; 12(2):451-5. PubMed ID: 8570224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor suppressor genes in the 9p21 gene cluster are selective targets of inactivation in neuroendocrine gastroenteropancreatic tumors.
    Lubomierski N; Kersting M; Bert T; Muench K; Wulbrand U; Schuermann M; Bartsch D; Simon B
    Cancer Res; 2001 Aug; 61(15):5905-10. PubMed ID: 11479232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypermethylation of the p16 gene in nasopharyngeal carcinoma.
    Lo KW; Cheung ST; Leung SF; van Hasselt A; Tsang YS; Mak KF; Chung YF; Woo JK; Lee JC; Huang DP
    Cancer Res; 1996 Jun; 56(12):2721-5. PubMed ID: 8665502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B.
    Herman JG; Jen J; Merlo A; Baylin SB
    Cancer Res; 1996 Feb; 56(4):722-7. PubMed ID: 8631003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incidence of chromosome 9p21 abnormalities and deletions of tumor suppressor genes p15(INK4b)/p16(INK4a)/p14(ARF) in patients with acute lymphoblastic leukemia.
    Faderl S; Estrov Z; Kantarjian HM; Thomas D; Cortes J; Manshouri T; Chan CC; Hays KJ; Pierce S; Albitar M
    Cytokines Cell Mol Ther; 1999 Sep; 5(3):159-63. PubMed ID: 10641574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p16 (CDKN2/MTS1) gene deletions are rare in prostatic carcinomas in the United States and Japan.
    Mangold KA; Takahashi H; Brandigi C; Wada T; Wakui S; Furusato M; Boyd J; Chandler FW; Allsbrook WC
    J Urol; 1997 Mar; 157(3):1117-20. PubMed ID: 9072554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of p15INK4B and p16INK4A gene alterations in primary cervical carcinoma tissues and cell lines with human papillomavirus infection.
    Kim JW; Namkoong SE; Ryu SW; Kim HS; Shin JW; Lee JM; Kim DH; Kim IK
    Gynecol Oncol; 1998 Jul; 70(1):75-9. PubMed ID: 9698478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.